Latest Conference Articles

Han and colleagues will explore the most important factors to consider when selecting an appropriate biologic treatment in an upcoming panel at AAD.

The Dermatology Times® team is in New Orleans, Louisiana to showcase innovative solutions in dermatologic care.

Among the more than 300 sessions to be held at this week's American Academy of Dermatology meeting in New Orleans, Louisiana, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.

Anna Bar, MD, FAAD returns to AAD as part of the interactive “How Would You Reconstruct It?” session.

In conjunction with AAD 2023, the Skin of Color Society presents an opportunity to learn about racial disparities in dermatologic care and best practices to serve patients of color.

This weekend's American Academy of Dermatology (AAD) meeting in New Orleans has key opinion leaders excited.

Monica K. Li, MD, shares what to expect at her co-directed global microneedling techniques session at AAD 2023.

Answer our new poll leading up to AAD 2023.

As sessions wrap up each day at AAD, there are numerous must-see places in New Orleans.

Click here to answer our new AAD 2023 poll.

Adam Friedman, MD, FAAD, offers first-time AAD attendees tips on how to navigate the annual meeting in New Orleans.

Data published in Nucleic Acids Research builds on previous studies investigating the benefits of sarecycline for acne vulgaris compared to other antibiotics.

Click here to answer this week's poll.

Conferences provide valuable information and resources to help you grow in the dermatology space.

Updates from Incyte’s dermatology portfolio include late-breaking data on ruxolitinib cream and povorcitinib for vitiligo.

Study participants saw a rapid decrease in inflammatory lesions with the once-daily antibiotic, antibacterial, and retinoid gel.

Look back at 10 of the innovative sessions presented at the 2023 Winter Clinical Hawaii Conference in Kohala Coast, Hawaii.

From topical antibiotics like clindamycin to biologic injectables like adalimumab to surgical options like deroofing, treatment for HS can come in many forms.

Emmy Graber, MD, MBA, covered it all in her Winter Clinical Miami talk, offering take-home pearls via patient case studies.

With now more than 6 months of real-world use for baricitinib available, what challenges still remain for the alopecia areata treatment and what other agents are on the horizon?

Treatment is not mandatory and, in fact, clinicians are still without an FDA-approved treatment option, but parents often insist on some sort of action.

Topicals, orals, biologics—Armstrong’s Winter Clinical Miami presentation focused on new treatment options for patients with psoriasis with an emphasis on real-world observations.

Alexandra Golant, MD, and Seemal Desai, MD, weigh the pros and cons of each treatment option for atopic dermatitis, considering mechanism of action, efficacy, and safety. Which will emerge victorious?

“So much new in the world of pediatric dermatology—new and novel treatments for atopic dermatitis, hemangiomas, childhood blistering diseases, warts. We are practicing during the Golden Age of dermatology,” Swanson says.

The proportion of patients who achieved a SALT score < 10 jumped from 24.9% at 36 weeks to 28.9% at 52 weeks in the BARI 4-mg arm and 11.8% to 15.3% in the BARI 2-mg arm.

When evaluating treatment options for patients with psoriasis, rosacea, or eczema, clinicians should employ a top-down approach and remember to consider topical therapies.

Five days of treatment with the topical therapy measurably improved symptoms and emotional/functional impact for patients with actinic keratosis at week 8.

“We're going to talk about medical hair loss in terms of diagnosis and treatment and really try to make it very easy,” Leavitt says.